Sugar-Based Excipients

Global Sugar-Based Excipients Market to Reach US$1.8 Billion by 2032

The global market for Sugar-Based Excipients estimated at US$1.3 Billion in the year 2025, is expected to reach US$1.8 Billion by 2032, growing at a CAGR of 4.0% over the analysis period 2025-2032. Actual Sugars Product, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$653.1 Million by the end of the analysis period. Growth in the Sugar Alcohols Product segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$414.4 Million While China is Forecast to Grow at 7.5% CAGR

The Sugar-Based Excipients market in the U.S. is estimated at US$414.4 Million in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$425.0 Million by the year 2032 trailing a CAGR of 7.5% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Sugar-Based Excipients Market - Key Trends and Drivers Summarized

Why Are Sugar-Based Excipients Crucial in Pharmaceuticals?

Sugar-based excipients play a vital role in pharmaceutical formulations, where they are used as fillers, binders, and sweeteners to improve the taste and stability of medicines. These excipients are particularly valuable in pediatric and geriatric formulations, where the palatability of medications is a key factor in compliance. Sucrose, glucose, and lactose are among the most commonly used sugar-based excipients, providing sweetness and aiding in the proper release of active ingredients. The growing demand for orally disintegrating tablets (ODTs) and chewable tablets has further expanded the use of sugar-based excipients, as these dosage forms rely on excipients that enhance mouthfeel and dissolution.

What Technological Advancements Are Shaping the Sugar-Based Excipients Market?

Technological innovations in drug delivery systems have led to the development of more effective sugar-based excipients. Manufacturers are focusing on creating excipients that not only enhance the taste of medications but also improve drug bioavailability and stability. The advent of multifunctional excipients has enabled pharmaceutical companies to reduce the number of components in formulations, simplifying production processes and improving product performance. Additionally, advancements in taste-masking technologies are allowing sugar-based excipients to be used in bitter-tasting drugs, making them more palatable for patients. This is particularly important in the development of pediatric and geriatric medicines, where ease of consumption is critical.

Which Segments Are Leading the Sugar-Based Excipients Market?

Common product types include sucrose, lactose, and mannitol, with sucrose being the most widely used due to its sweetness and solubility. In terms of form, sugar-based excipients are available as powders, granules, and syrups, with powders being the most common form in tablet formulations. The pharmaceutical industry is the largest end-user of sugar-based excipients, followed by nutraceuticals and food supplements. Geographically, North America and Europe dominate the market due to their robust pharmaceutical industries, while emerging markets in Asia-Pacific are expected to grow due to increased drug production and rising healthcare spending.

What Drives Growth in the Sugar-Based Excipients Market?

The growth in the Sugar-Based Excipients market is driven by several factors, including the increasing demand for orally disintegrating tablets and chewable formulations, as well as advancements in drug delivery systems. The rising prevalence of chronic diseases and the growing pediatric and geriatric populations are boosting the demand for easy-to-administer dosage forms, where sugar-based excipients play a crucial role. Additionally, the growing nutraceuticals market is expanding the use of sugar-based excipients in dietary supplements. As pharmaceutical companies continue to innovate in taste-masking and multifunctional excipients, the market is poised for continued growth.

SCOPE OF STUDY:

The report analyzes the Sugar-Based Excipients market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners); Type (Powder / Granule, Crystal, Syrup, Direct Compression Sugars); Formulation (Oral, Topical, Parenteral, Other Formulations)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• Archer Daniels Midland Company
• Ashland, Inc.
• Associated British Foods PLC
• BASF SE
• Cargill, Inc.
• Colorcon, Inc.
• DFE Pharma GmbH & Co. KG
• FMC Corporation
• Molkerei MEGGLE Wasserburg GmbH & Co. KG
• Roquette Freres S.A.
• The Lubrizol Corporation

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more